Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 8.50
+0.50 (6.25%)
Jan 22, 2026, 4:30 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 36.65 million as of January 22, 2026. Its market cap has increased by 0.22% in one year.
Market Cap
36.65M
Enterprise Value
33.97M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.50
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 36.65M, a decrease of -67.53%. That is a compound annual growth rate of -23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 35.54M | -8.57% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 94.05M |
| 4basebio | 91.32M |
| SkinBioTherapeutics | 48.52M |
| Hemogenyx Pharmaceuticals | 41.56M |
| hVIVO | 37.76M |
| ImmuPharma | 34.69M |
| Poolbeg Pharma | 32.42M |
| Arecor Therapeutics | 31.15M |